Stocks Health care NMTC

NASDAQ · Health care

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

NEUROONE MEDICAL TECHNOLOGIES Corp brought in $9.5M of revenue over the twelve months to June 30, 2026, up 42.8% from a year earlier. It posted a net loss of $7.4M. In fiscal 2025 capital spending exceeded operating cash flow by $2.9M. At June 30, 2026 it held $2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch NMTC in 60 seconds

What NEUROONE MEDICAL TECHNOLOGIES Corp does

NEUROONE MEDICAL TECHNOLOGIES Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NMTC.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where NMTC ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What NEUROONE MEDICAL TECHNOLOGIES Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 27, 2026
   Other event 8-K
2. August 13, 2026
   Quarterly report 10-Q · period to June 30, 2026Revenue rose 16% to $2M versus the same quarter last year; diluted EPS -$0.28 versus -$0.19.
3. August 13, 2026
   Quarterly results 8-K
4. July 14, 2026
   Passive stake changed SCHEDULE 13G/A
5. June 12, 2026
   Securities offering prospectus 424B5
6. June 12, 2026
   Other event 8-K
7. June 12, 2026
   Quarterly report (amended) 10-Q/A · period to March 31, 2026Revenue rose 34% to $1.9M versus the same quarter last year; diluted EPS -$0.28 versus -$0.44.
8. May 29, 2026
   Conflict minerals disclosure SD
9. May 29, 2026
   Conflict minerals disclosure SD
10. May 22, 2026
    Past results no longer reliable 8-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on September 8, 2026. Insider transactions on SEC

Insider trades

What the people running NEUROONE MEDICAL TECHNOLOGIES Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders bought $67K and sold $31.8K worth of shares in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns NMTC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: Sio Capital Management, LLC 4.72% (November 12, 2025); Lytton Laurence W 2.6% (May 15, 2025); AWM Investment Company, Inc. 4.8% (May 9, 2025); James E. Besser 4.9% (February 14, 2025); Wilmot B. Harkey 2.6% (November 14, 2024).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

2 insiders reported holding 220,691 shares in total, about $293.5K at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about NMTC

What does NEUROONE MEDICAL TECHNOLOGIES Corp do?

NEUROONE MEDICAL TECHNOLOGIES Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NMTC.

Is NEUROONE MEDICAL TECHNOLOGIES Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $7.4M on revenue of $9.5M.

How much revenue does NEUROONE MEDICAL TECHNOLOGIES Corp make?

Over the twelve months to June 30, 2026 NEUROONE MEDICAL TECHNOLOGIES Corp reported revenue of $9.5M. That is 42.8% more than a year earlier.

When did NEUROONE MEDICAL TECHNOLOGIES Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 8, 2026.

Similar companies

Compare NMTC with

Compare NMTC with any company

Follow NMTC

Get an email when NEUROONE MEDICAL TECHNOLOGIES Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow NMTC: get an email when it files

Where the numbers come from

Financial figures are the values NEUROONE MEDICAL TECHNOLOGIES Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.